Q&A: More research, policies needed to ‘curb the rising costs’ of liver cancer care

Patients with hepatocellular carcinoma carried a “significantly higher” cancer-related financial burden compared with those with cirrhosis, according to data published in Clinical Gastroenterology and Hepatology.To analyze patient liabilities and Medicare payments in the first year following HCC diagnosis, Amit Singal, MD, medical director of the liver tumor program and clinical chief of hepatology at UT Southwestern Medical Center, and colleagues used the Surveillance, Epidemiology and End Results program-Medicare database to identify 4,525 adults diagnosed with HCC between 2011Read More

Generated by Feedzy